NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

特殊学名药的全球市场:产业趋势,市场占有率、规模、成长率、机会及预测(2021年~2026年)

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版商 IMARC Services Private Limited 商品编码 999876
出版日期 内容资讯 英文 144 Pages
商品交期: 2-3个工作天内
价格
特殊学名药的全球市场:产业趋势,市场占有率、规模、成长率、机会及预测(2021年~2026年) Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
出版日期: 2021年05月20日内容资讯: 英文 144 Pages
简介

全球特殊学名药的市场规模,2020年达到了573亿美元。特殊学名药,是专利到期的特殊医药品的非专利版。这些药使用于癌症,自体免疫疾病,癫痫,HIV,肝炎,多发性硬化症,类风湿性关节炎等慢性疾病或并发症的治疗。特殊非专利,因为不需高价的开发费与行销费用,比品牌医药品成本效益高。

高龄化人口增加,多数品牌特殊医药品的专利到期,癌症、多发性硬化症、HIV等的各种致死性疾病的盛行率增加,来自医疗保健供应商的成本控制对策,新兴市场的成长等,成为市场成长的促进因素。全球特殊学名药市场,预计今后5年显示强力的成长。

本报告提供全球特殊学名药市场的相关调查,提供产业趋势,市场预测,各给药途径、适应症、流通管道、地区的市场分析,竞争情形,主要企业的简介等资讯。

目录

第1章 序文

第2章 范围和调查方法

第3章 摘要整理

第4章 全球特殊学名药市场:简介

第5章 特殊学名药的有利点

第6章 全球特殊学名药市场

  • 市场概要
  • 市场成果
  • COVID-19的影响
  • 各给药途径的市场区隔
  • 各适应症的市场区隔
  • 各流通管道的市场区隔
  • 各地区的市场区隔
  • SWOT分析
    • 概要
    • 优势
    • 弱点
    • 市场机会
    • 威胁
  • 价值链分析
  • 波特五力分析
  • 主要的市场成长要素与成功因素

第7章 各给药途径的市场区隔

  • 注射剂
  • 口服
  • 其他

第8章 各适应症的市场区隔

  • 肿瘤学
  • 自体免疫疾病
  • 感染疾病
  • 其他

第9章 各流通管道的市场区隔

  • 零售药局
  • 专门药局
  • 医院药局

第10章 各地区的市场区隔

  • 北美
    • 市场概要
    • 市场成果
    • 各国市场区隔
    • 美国
    • 加拿大
  • 欧洲
    • 市场概要
    • 市场成果
    • 各国市场区隔
    • 义大利
    • 德国
    • 法国
    • 英国
    • 西班牙
  • 亚太地区
    • 市场概要
    • 市场成果
    • 各国市场区隔
    • 日本
    • 中国
    • 印度
    • 韩国
  • 南美
    • 市场概要
    • 市场成果
    • 各国市场区隔
    • 巴西
    • 墨西哥
  • 中东、非洲
    • 市场概要
    • 市场成果

第11章 竞争情形

  • 市场结构
  • 主要企业
  • 主要企业的简介
    • Teva Pharmaceuticals Industries
    • Akorn, Inc.
    • Mylan N.V.
    • Mallinckrodt
    • Sandoz International GmbH
    • Pfizer, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals
    • Apotex Corp.
    • Endo International plc.
目录
Product Code: SR1020C78_Report

The global specialty generics market reached a value of US$ 57.3 Billion in 2020. Looking forward, IMARC Group expects the market to exhibit strong growth during the next five years. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Report Scope:

  • Historical, Current and Future Market Trends

Market Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Market Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others

Market Breakup by Indication:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

Market Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Competitive Landscape:

  • The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Key Questions Answered in This Report:

  • How has the global specialty generics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global specialty generics industry?
  • What has been the impact of COVID-19 on the global specialty generics industry?
  • What is the breakup of the global specialty generics market based on the indication?
  • What is the breakup of the global specialty generics market based on the route of administration?
  • What is the breakup of the global specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the global specialty generics industry?
  • What are the key driving factors and challenges in the global specialty generics market?
  • What is the structure of the global specialty generics industry and who are the key players?
  • What is the degree of competition in the global specialty generics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Impact of COVID-19
  • 6.4 Market Breakup by Route of Administration
  • 6.5 Market Breakup by Indication
  • 6.6 Market Breakup by Distribution Channel
  • 6.7 Market Breakup by Region
  • 6.8 Market Forecast
  • 6.9 SWOT Analysis
    • 6.9.1 Overview
    • 6.9.2 Strengths
    • 6.9.3 Weaknesses
    • 6.9.4 Opportunities
    • 6.9.5 Threats
  • 6.10 Value Chain Analysis
  • 6.11 Porters Five Forces Analysis
    • 6.11.1 Overview
    • 6.11.2 Bargaining Power of Buyers
    • 6.11.3 Bargaining Power of Suppliers
    • 6.11.4 Degree of Competition
    • 6.11.5 Threat of New Entrants
    • 6.11.6 Threat of Substitutes
  • 6.12 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hospital Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Overview
    • 10.1.2 Market Performance
    • 10.1.3 Market Breakup by Country
    • 10.1.4 United States
      • 10.1.4.1 Market Trends
      • 10.1.4.2 Market Forecast
    • 10.1.5 Canada
      • 10.1.5.1 Market Trends
      • 10.1.5.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Overview
    • 10.2.2 Market Performance
    • 10.2.3 Market Breakup by Country
    • 10.2.4 Italy
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Germany
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 France
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 United Kingdom
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
    • 10.2.8 Spain
      • 10.2.8.1 Market Trends
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Overview
    • 10.3.2 Market Performance
    • 10.3.3 Market Breakup by Country
    • 10.3.4 Japan
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 China
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 India
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 South Korea
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Market Overview
    • 10.4.2 Market Performance
    • 10.4.3 Market Breakup by Country
    • 10.4.4 Brazil
      • 10.4.4.1 Market Trends
      • 10.4.4.2 Market Forecast
    • 10.4.5 Mexico
      • 10.4.5.1 Market Trends
      • 10.4.5.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Overview
    • 10.5.2 Market Performance
    • 10.5.3 Market Forecast

11 Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Teva Pharmaceuticals Industries
    • 11.3.2 Akorn, Inc.
    • 11.3.3 Mylan N.V.
    • 11.3.4 Mallinckrodt
    • 11.3.5 Sandoz International GmbH
    • 11.3.6 Pfizer, Inc.
    • 11.3.7 Sun Pharmaceutical Industries Ltd.
    • 11.3.8 Valeant Pharmaceuticals
    • 11.3.9 Apotex Corp.
    • 11.3.10 Endo International plc.

List of Figures

  • Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
  • Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2020
  • Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
  • Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
  • Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 7: Global: Specialty Generics Industry: SWOT Analysis
  • Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
  • Figure 9: Global: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2015 & 2020
  • Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2015 & 2020
  • Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2015 & 2020
  • Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2015 & 2020
  • Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2015 & 2020
  • Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2015 & 2020
  • Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2021-2026
  • Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2015 & 2020
  • Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2021-2026
  • Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2015 & 2020
  • Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2021-2026
  • Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2020
  • Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2021-2026
  • Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2021-2026
  • Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2021-2026
  • Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2021-2026
  • Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
  • Table 11: Global: Specialty Generics Market Structure
  • Table 12: Global: Specialty Generics Market: Key Players